Medicare AdvantageCoverageMedium impact
MA11.014g, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toe Nails
Independence Blue Cross·Podiatry, Dermatology, Family Medicine +1 more·Medical Policy
Effective date
Apr 2, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.014g for debridement of mycotic and symptomatic non-mycotic hypertrophic toe nails has been reissued with updates effective April 2, 2025. This policy affects coverage and billing requirements for nail debridement procedures under Medicare Advantage plans.
Action Required
By April 2, 2025: Billing team must review the full updated policy MA11.014g for nail debridement procedures to understand any changes to coverage criteria, documentation requirements, or prior authorization needs. Access the complete policy document from the source URL to identify specific billing code changes and update billing protocols accordingly.